A commercial kit (Cordia-IC) from Cordis Laboratory, Miami, Fla., was compared with the Raji cell radioimmunoassay for its ability to detect circulating immune complexes (CIC) in sera from 30 control subjects and 118 patients with infectious diseases. The 118 patients were categorized into the following groups: (i) 23 patients with bacterial endocarditis, (ii) 
The significance of circulating immune complexes (CIC) in patients with chronic antigenic stimulation related to infections, autoimmune diseases, or certain malignancies is now well established (1, 3, 6, 7) . The detection and quantitation of these CIC are important for diagnosis as well as for monitoring the response of patients to therapy (2) . Unfortunately, the current assays for the detection of CIC are not applicable for widespread use in routine clinical laboratories. Such disadvantages as the lack of automation and standardization and the use of radioactive compounds restrict the availability of these assays to specialized centers. Recently, Cordis Laboratory, Miami, Fla., developed a commercial kit (Cordia-IC) for CIC measurement by an enzyme-linked immunosorbent assay (ELISA) Cordia-IC ELISA. The Cordia-IC ELISA was performed according to instructions included with the kit. Supplied in the kit were goat Clq-coated plastic disks, alkaline phosphatase-conjugated goat anti-human immunoglobulin G and M, strong-and weak-positive controls, AHG, negative control, p-nitrophenyl phosphate, and buffers. Serum samples were diluted 1:100 in 0.01 M phosphate-buffered saline containing 0.05% Tween 20 and 6.0% bovine serum albumin. Simultaneously analyzed with the test samples were dilutions of the strong-positive (1:1, 1:4, 1:16, and 1:64), weak-positive (1:100), and negative controls. All samples were tested in duplicate. A Clq-coated disk was added to each sample and incubated for 45 min at 37°C in a shaking water bath. The disk was then removed and washed five times with phosphate-buffered saline. Enzyme conjugate was added to the disk, and the same incubation was repeated. The disk was removed, washed another five times, and then added to 0.01% p-nitrophenyl phosphate substrate. The reaction was terminated after 20 min by the addition of 3.0 M sodium hydroxide, and A405 was determined. A standard curve was constructed from the absorbance of the dilutions of the strong-positive control and its known microgram eq ofAHG. Results were obtained by reference to the standard curve and were expressed as microgram eq of AHG per ml.
Statistical analysis. The coefficients of variation (CVs) were calculated for intraassay variability and interassay reproducibility of the ELISA and Raji cell tests. The correlation between the Raji cell RIA and the Cordia-IC was tested with Pearson's correlation coefficient. Analysis for differences in the amount of CIC among clinical groups was performed with a two-tailed Student's t test for unpaired data. RESULTS Patients. A total of 118 serum specimens was collected from individual patients. An additional 30 serum specimens were obtained from a group of healthy blood donors.
The endocarditis group (group 1) consisted of 23 patients.
Endocarditis was related to Staphylococcus aureus in 14 patients, to Staphylococcus epidermidis in 2 patients, to viridans streptococci in 2 patients, to Escherichia coli in 2 patients, and to Candida albicans in 1 patient. Also included within this group were two additional patients, one with S. epidermidis infection of a ventriculoatrial shunt and one with S. epidermidis infection of a LeVeen shunt. Intravascular catheter-related and arteriovenous access infections (group 2) were diagnosed in 41 patients. In 32 patients, the bacteremia was related to an infected intravascular catheter, whereas in 9 patients, the bacteremia was related to an infected arteriovenous access device. In 54 patients with S. aureus bacteremia, a deep tissue focus of infection was found (group 3). Osteomyelitis was identified as the source of bacteremia in 11 patients, pneumonia was the source in 10 patients, septic arthritis was the source in 8 patients, and burn eschars or other wound infections were the sources in 25 patients. Characteristics of the Cordia-IC ELISA and the Raji cell RIA. The Cordia-IC ELISA intraassay CV for an identical sample was 4.0%. The equivalent intraassay CV for the Raji cell RIA was 8.0%. The CV for the interassay reproducibility for 10 consecutive days was 8.7% for the Cordia-IC ELISA and 20.0% for the Raji cell RIA.
CIC in patient groups. CIC amounts detected by both the Raji cell RIA and the Cordia-IC ELISA were less than 12.5 ,ug eq of AHG per ml in all 30 serum specimens from healthy blood donors. Among the 23 patients with endocarditis (group 1), CIC values greater than 12.5 jxg eq of AHG per ml were detected in 19 patients (82.6%; mean, 73.6 ktg eq of AHG per ml) by Cordia-IC ELISA and in 16 patients (69.6%; mean, 54.8 ,g eq ofAHG per ml) by the Raji cell RIA. There was no statistically significant difference between the amounts of CIC detected in the patients from group 1 by the two assays (P = 0.44).
In ,ug eq ofAHG per ml) in only 32 (59.3%) of these 54 patients. Again, there was no statistically significant difference between the amounts of CIC detected by the Cordia-IC ELISA and the Raji cell RIA (P = 0.44).
Correlation of Cordia-IC ELISA and Raji cell RIA. The CIC amounts detected by both assays in the 118 patients were significantly different from the CIC amounts found in the 30 control subjects (P < 0.001). Figure 1 compares the CIC values obtained by the Cordia-IC ELISA and the Raji cell RIA. A statistically significant correlation was found between the two assays (r = 0.64, P < 0.001).
DISCUSSION
Although important diagnostic and therapeutic information may be gained by the detection of CIC, reliable techniques for CIC quantitation are not readily available in most routine clinical laboratories. Certainly, as Jacob et al. (5) mentioned, with more than 40 different assays now reported for the detection of CIC, more widespread application of this technology is possible. Much of the confusion results from an inherent variability among the tests related to the different principles and reactivities associated with each method. This variability has led to the recommendation by some investigators that serum suspected of containing CIC be screened by more than one methodology (9) .
The most common assays rely upon the binding of immune complexes by either the Clq component of complement or the Raji cell surface receptors (9) . The Cordia-IC ELISA used a solid phase (plastic disk) coated with Clq for the binding of the CIC. An enzyme-conjugated antibody was then used to quantitate the amount of CIC bound to the immobilized Clq. In the Raji cell RIA, the amount of CIC bound to the cell surface receptors is quantitated by 125I-labeled protein A. Both the Cordia-IC ELISA and the Raji cell RIA used dilutions of AHG as a control. The CVs of the Cordia-IC ELISA were less than those of the Raji cell RIA in both intraassay variability (4.0 versus 8.0%) and interassay reproducibility (8.7 versus 20.0%).
Both the Cordia-IC ELISA and the Raji cell RIA were used to quantitate CIC. There were no significant differences between the two assays in CIC amount found in the three groups of patients with infectious diseases. The Cordia-IC ELISA detected more patients with CIC values above 12.5 tg eq of AHG per ml in each of the groups. value for each group was also higher in the Cordia-IC ELISA. None of these differences, however, proved to be statistically significant. The sensitivity of the Cordia-IC ELISA in our hands was 5 ,ug eq of AHG per ml. When the results obtained in the three groups were analyzed, there was a good overall correlation between the Cordia-IC ELISA and the Raji cell RIA (Fig. 1) 
